Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G)
Clinical trial NCT04931849 · WITHDRAWN
Trial details
- NCT number
- NCT04931849
- Sponsor
- University of Rochester
- Status
- WITHDRAWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-06
- Primary completion
- 2023-10-11
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.